|
Sign In to gain access to subscriptions and/or personal tools.
|
Methylphenidate for fatigue in advanced cancer: A prospective open-label pilot study
Nabeel Sarhill, MD
Harry R. Horvitz Center for Palliative Medicine, a World Health Organization Demonstration Project in Palliative Medicine, Cleveland Clinic Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio
Declan Walsh, FACP, FRCP (Edin)
Harry R. Horvitz Center for Palliative Medicine, a World Health Organization Demonstration Project in Palliative Medicine, Cleveland Clinic Taussig Cancer Center, Harry R. Horvitz Chair in Palliative Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
Kristine A. Nelson, MD
Harry R. Horvitz Center for Palliative Medicine, a World Health Organization Demonstration Project in Palliative Medicine, Cleveland Clinic Taussig Cancer Center, Palliative Medicine, Cleveland Clinic Foundation, Cleveland, Ohio
Jade Homsi, MD
Harry R. Horvitz Center for Palliative Medicine, a World Health Organization Demonstration Project in Palliative Medicine, Cleveland Clinic Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio
Susan LeGrand, MD
Harry R. Horvitz Center for Palliative Medicine, a World Health Organization Demonstration Project in Palliative Medicine, Cleveland Clinic Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio
Mellar P. Davis, MD
Harry R. Horvitz Center for Palliative Medicine, a World Health Organization Demonstration Project in Palliative Medicine, Cleveland Clinic Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland, Ohio
Psychostimulants such as methylphenidate are used for fatigue in cancer patients. We report a prospective, open-label, pilot study of the successful use of methylphenidate to treat fatigue in nine of 11 consecutive patients with advanced cancer. Seven had received radiation or chemotherapy, a median of three weeks (range from one to 30 weeks) prior to methylphenidate. A rapid onset of benefit was noted, even in the presence of mild anemia. Sedation and pain also improved in some. Only one patient had side effects severe enough to stop the medication.
Key Words: cancer fatigue methylphenidate psychostimulant symptom management
American Journal of Hospice and Palliative Medicine®, Vol. 18, No. 3,
187-192 (2001)
DOI: 10.1177/104990910101800310

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
W. Lasheen, D. Walsh, F. Mahmoud, M. P. Davis, N. Rivera, and D. S. Khoshknabi
Methylphenidate Side Effects in Advanced Cancer: A Retrospective Analysis
American Journal of Hospice and Palliative Medicine,
February 1, 2010;
27(1):
16 - 23.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Radbruch, F. Strasser, F. Elsner, J. F. Goncalves, J. Loge, S. Kaasa, F. Nauck, P. Stone, and the Research Steering Committee of the European As
Fatigue in palliative care patients -- an EAPC approach
Palliative Medicine,
January 1, 2008;
22(1):
13 - 32.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. K. Carroll, S. Kohli, K. M. Mustian, J. A. Roscoe, and G. R. Morrow
Pharmacologic Treatment of Cancer-Related Fatigue
Oncologist,
May 1, 2007;
12(suppl_1):
43 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Lyness
End-of-Life Care: Issues Relevant to the Geriatric Psychiatrist
Focus,
January 1, 2007;
5(4):
459 - 471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sood, D. L. Barton, and C. L. Loprinzi
Use of methylphenidate in patients with cancer
American Journal of Hospice and Palliative Medicine,
January 1, 2006;
23(1):
35 - 40.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Schillerstrom, M. S. Horton, and D. R. Royall
The Impact of Medical Illness on Executive Function
Psychosomatics,
December 1, 2005;
46(6):
508 - 516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Ng, S. Li, C. Recklitis, D. Neuberg, S. Chakrabarti, B. Silver, and L. Diller
A comparison between long-term survivors of Hodgkin's disease and their siblings on fatigue level and factors predicting for increased fatigue
Ann. Onc.,
December 1, 2005;
16(12):
1949 - 1955.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Lyness
End-of-Life Care: Issues Relevant to the Geriatric Psychiatrist
Focus,
April 1, 2005;
3(2):
341 - 353.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Fleishman
Treatment of Symptom Clusters: Pain, Depression, and Fatigue
J Natl Cancer Inst Monographs,
July 1, 2004;
2004(32):
119 - 123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Iop, A. M. Manfredi, and S. Bonura
Fatigue in cancer patients receiving chemotherapy: an analysis of published studies
Ann. Onc.,
May 1, 2004;
15(5):
712 - 720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Wharton
Sleeping with the Enemy: Treatment of Fatigue in Individuals with Cancer
Oncologist,
April 1, 2002;
7(2):
96 - 99.
[Full Text]
[PDF]
|
 |
|
|
|